Rizwana F Sproule Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Rizwana F Sproule.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Rizwana F Sproule. Rizwana F Sproule is VP Regulatory Affairs in Kite Pharma, Inc. ($KITE).
Latest Insider Trading Transactions of Rizwana F Sproule
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 17 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Option Exercise | M | 1.35 | 8,500 | 11,475 | 95,830 | |
Mar 17 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 48.07 | 189 | 9,085 | 10,211 | 10.4 K to 10.2 K (-1.82 %) |
Mar 17 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 46.55 | 499 | 23,228 | 10,400 | 10.9 K to 10.4 K (-4.58 %) |
Mar 17 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 45.12 | 7,812 | 352,477 | 10,899 | 18.7 K to 10.9 K (-41.75 %) |
Mar 17 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Buy | M | 1.35 | 8,500 | 11,475 | 18,711 | 10.2 K to 18.7 K (+83.24 %) |
Feb 19 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Option Exercise | M | 1.35 | 9,567 | 12,915 | 104,330 | |
Feb 19 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 46.01 | 100 | 4,601 | 8,741 | 8.8 K to 8.7 K (-1.13 %) |
Feb 19 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 45.07 | 9,467 | 426,678 | 8,841 | 18.3 K to 8.8 K (-51.71 %) |
Feb 19 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Buy | M | 1.35 | 9,567 | 12,915 | 18,308 | 8.7 K to 18.3 K (+109.45 %) |
Jan 19 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Option Exercise | M | 1.35 | 2,767 | 3,735 | 113,897 | |
Jan 19 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Option Exercise | M | 1.35 | 6,800 | 9,180 | 116,664 | |
Jan 19 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 58.92 | 198 | 11,666 | 8,741 | 8.9 K to 8.7 K (-2.22 %) |
Jan 19 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 57.74 | 852 | 49,194 | 8,939 | 9.8 K to 8.9 K (-8.70 %) |
Jan 19 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 56.70 | 230 | 13,041 | 9,791 | 10 K to 9.8 K (-2.30 %) |
Jan 19 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 55.67 | 635 | 35,350 | 10,021 | 10.7 K to 10 K (-5.96 %) |
Jan 19 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 54.58 | 355 | 19,376 | 10,656 | 11 K to 10.7 K (-3.22 %) |
Jan 19 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 53.55 | 497 | 26,614 | 11,011 | 11.5 K to 11 K (-4.32 %) |
Jan 19 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Buy | M | 1.35 | 2,767 | 3,735 | 11,508 | 8.7 K to 11.5 K (+31.66 %) |
Jan 19 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 57.09 | 800 | 45,672 | 8,741 | 9.5 K to 8.7 K (-8.38 %) |
Jan 19 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 55.60 | 1,918 | 106,641 | 9,541 | 11.5 K to 9.5 K (-16.74 %) |
Jan 19 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 55.07 | 3,166 | 174,352 | 11,459 | 14.6 K to 11.5 K (-21.65 %) |
Jan 19 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 53.89 | 645 | 34,759 | 14,625 | 15.3 K to 14.6 K (-4.22 %) |
Jan 19 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 52.27 | 271 | 14,165 | 15,270 | 15.5 K to 15.3 K (-1.74 %) |
Jan 19 2016 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Buy | M | 1.35 | 6,800 | 9,180 | 15,541 | 8.7 K to 15.5 K (+77.79 %) |
Dec 21 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Option Exercise | A | 63.87 | 8,800 | 562,056 | 8,800 | |
Dec 21 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Grant | A | 0.00 | 5,800 | 0 | 8,741 | 2.9 K to 8.7 K (+197.21 %) |
Dec 17 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Option Exercise | M | 1.35 | 9,567 | 12,915 | 123,464 | |
Dec 17 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 65.38 | 432 | 28,244 | 2,941 | 3.4 K to 2.9 K (-12.81 %) |
Dec 17 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 64.64 | 3,352 | 216,673 | 3,373 | 6.7 K to 3.4 K (-49.84 %) |
Dec 17 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 63.73 | 2,410 | 153,589 | 6,725 | 9.1 K to 6.7 K (-26.38 %) |
Dec 17 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 62.70 | 3,373 | 211,487 | 9,135 | 12.5 K to 9.1 K (-26.97 %) |
Dec 17 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Buy | M | 1.35 | 9,567 | 12,915 | 12,508 | 2.9 K to 12.5 K (+325.30 %) |
Nov 18 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Option Exercise | M | 1.35 | 9,567 | 12,915 | 133,031 | |
Nov 18 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 80.27 | 172 | 13,806 | 2,941 | 3.1 K to 2.9 K (-5.53 %) |
Nov 18 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 79.27 | 944 | 74,831 | 3,113 | 4.1 K to 3.1 K (-23.27 %) |
Nov 18 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 78.49 | 5,236 | 410,974 | 4,057 | 9.3 K to 4.1 K (-56.34 %) |
Nov 18 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 77.62 | 1,791 | 139,017 | 9,293 | 11.1 K to 9.3 K (-16.16 %) |
Nov 18 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 76.46 | 1,424 | 108,879 | 11,084 | 12.5 K to 11.1 K (-11.38 %) |
Nov 18 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Buy | M | 1.35 | 9,567 | 12,915 | 12,508 | 2.9 K to 12.5 K (+325.30 %) |
Oct 19 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Option Exercise | M | 1.35 | 9,567 | 12,915 | 142,598 | |
Oct 19 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 64.08 | 878 | 56,262 | 2,941 | 3.8 K to 2.9 K (-22.99 %) |
Oct 19 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 63.32 | 2,475 | 156,717 | 3,819 | 6.3 K to 3.8 K (-39.32 %) |
Oct 19 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 62.41 | 4,377 | 273,169 | 6,294 | 10.7 K to 6.3 K (-41.02 %) |
Oct 19 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 61.54 | 1,442 | 88,741 | 10,671 | 12.1 K to 10.7 K (-11.90 %) |
Oct 19 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 60.36 | 395 | 23,842 | 12,113 | 12.5 K to 12.1 K (-3.16 %) |
Oct 19 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Buy | M | 1.35 | 9,567 | 12,915 | 12,508 | 2.9 K to 12.5 K (+325.30 %) |
Sep 17 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Option Exercise | M | 1.35 | 9,567 | 12,915 | 152,165 | |
Sep 17 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 65.28 | 128 | 8,356 | 2,941 | 3.1 K to 2.9 K (-4.17 %) |
Sep 17 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 64.66 | 5,165 | 333,969 | 3,069 | 8.2 K to 3.1 K (-62.73 %) |
Sep 17 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 63.97 | 4,274 | 273,408 | 8,234 | 12.5 K to 8.2 K (-34.17 %) |
Sep 17 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Buy | M | 1.35 | 9,567 | 12,915 | 12,508 | 2.9 K to 12.5 K (+325.30 %) |
Aug 19 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Option Exercise | M | 1.35 | 9,567 | 12,915 | 161,732 | |
Aug 19 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 61.73 | 1,465 | 90,434 | 1,695 | 3.2 K to 1.7 K (-46.36 %) |
Aug 19 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 60.99 | 5,322 | 324,589 | 3,160 | 8.5 K to 3.2 K (-62.74 %) |
Aug 19 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 60.21 | 2,780 | 167,384 | 8,482 | 11.3 K to 8.5 K (-24.68 %) |
Aug 19 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Buy | M | 1.35 | 9,567 | 12,915 | 11,262 | 1.7 K to 11.3 K (+564.42 %) |
Jul 20 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Option Exercise | M | 1.35 | 9,567 | 12,915 | 171,299 | |
Jul 20 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 73.08 | 793 | 57,952 | 1,695 | 2.5 K to 1.7 K (-31.87 %) |
Jul 20 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 72.53 | 3,567 | 258,715 | 2,488 | 6.1 K to 2.5 K (-58.91 %) |
Jul 20 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 71.45 | 4,241 | 303,019 | 6,055 | 10.3 K to 6.1 K (-41.19 %) |
Jul 20 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 70.54 | 966 | 68,142 | 10,296 | 11.3 K to 10.3 K (-8.58 %) |
Jul 20 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Buy | M | 1.35 | 9,567 | 12,915 | 11,262 | 1.7 K to 11.3 K (+564.42 %) |
Jun 17 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Option Exercise | M | 1.35 | 9,567 | 12,915 | 180,866 | |
Jun 17 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 58.02 | 3,367 | 195,353 | 1,695 | 5.1 K to 1.7 K (-66.52 %) |
Jun 17 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 56.86 | 3,309 | 188,150 | 5,062 | 8.4 K to 5.1 K (-39.53 %) |
Jun 17 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 55.92 | 2,891 | 161,665 | 8,371 | 11.3 K to 8.4 K (-25.67 %) |
Jun 17 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Buy | M | 1.35 | 9,567 | 12,915 | 11,262 | 1.7 K to 11.3 K (+564.42 %) |
May 19 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Option Exercise | M | 1.35 | 9,567 | 12,915 | 190,433 | |
May 19 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 52.21 | 30 | 1,566 | 1,695 | 1.7 K to 1.7 K (-1.74 %) |
May 19 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 51.63 | 1,813 | 93,605 | 1,725 | 3.5 K to 1.7 K (-51.24 %) |
May 19 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 50.49 | 2,538 | 128,144 | 3,538 | 6.1 K to 3.5 K (-41.77 %) |
May 19 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Sell | S | 49.47 | 5,186 | 256,551 | 6,076 | 11.3 K to 6.1 K (-46.05 %) |
May 19 2015 | KITE | Kite Pharma, Inc. | Sproule Rizwana F | VP Regulatory Affai ... | Buy | M | 1.35 | 9,567 | 12,915 | 11,262 | 1.7 K to 11.3 K (+564.42 %) |
Page: 1